文献速递乳腺乳腺X线

使用自制定量工具(I-STRIP)定量对比增强能谱乳腺摄影中的强化:一项概念验证研究

Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): A proof-of-concept study.
PubMed 文献 · Eur J Radiol · 2018-07-24

本研究开发了含五个不同碘质量厚度腔室的自制定量工具I-STRIP,用于定量对比增强能谱乳腺摄影(CESM)的强化。体模实验显示定量不受腔室高度、大小、体模厚度及I-STRIP位置影响,但在体模周边因「乳腺内乳腺」伪影准确性降低。临床5例中 workflow 和图像质量未受影响,恶性病变的CGV显著高于良性病变(p=0.002)。

要点

  • I-STRIP可在不影响workflow和图像质量的前提下定量CESM强化。
  • 体模周边因「乳腺内乳腺」伪影导致定量准确性降低。
  • 恶性病变的CGV显著高于良性病变(p=0.002)。

核心结论

  • 体模和临床实验均表明CESM定量可行,且不影响workflow或图像质量;当前CESM成像方案似乎能够根据CGV区分乳腺良恶性病变。

研究设计与样本

  • 概念验证研究,开发含五个不同碘质量厚度腔室的自制定量工具I-STRIP;使用含已知IMT腔室的专用乳腺体模评估准确性;在5例患者中测试对图像质量和临床使用的影响;回顾性分析当前CESM方案能否根据CGV区分良恶性病变。

关键影像表现/征象

  • 体模实验中,对于不同IMT(1.5、3.0和7.5 mg l/cm2),定量不受腔室高度和大小、体模厚度及I-STRIP位置影响。
  • 体模周边因「乳腺内乳腺」伪影导致准确性降低。
  • 临床5例中,workflow和图像质量未受I-STRIP影响。

诊断标准与关键数值

  • 这些浸润性乳腺癌的平均IMT为2.1 mg l/cm2(范围1.3-3.4 mg l/cm2)。
  • 恶性病变的CGV显著高于良性病变(p=0.002)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Contrast-enhanced spectral mammography (CESM) is diagnostically superior to full-field digital mammography. An important improvement for CESM would be the ability to quantify enhancement. In this proof-of-concept study we present a method for quantifying CESM enhancement.

METHODS AND MATERIALS: We developed a custom-made quantifier tool (I-STRIP) containing five chambers, each filled with a different iodine mass thickness (IMT). CESM grey values of the recombined image (CGV) in the I-STRIP were used to quantify breast IMT. We evaluated the I-STRIP's accuracy using a dedicated breast phantom containing chambers with known IMT's. Furthermore, we tested the effect of the I-STRIP on image quality and clinical use in five patients. Retrospectively, we studied whether current CESM protocols could distinguish between malignant and benign lesions in terms of CGV.

RESULTS: Phantom experiments showed that quantification was independent of chamber height and size, phantom thickness and I-STRIP position for different IMT's (1.5, 3.0 and 7.5 mg l/cm2). Near the phantom's periphery accuracy was found to be lower due to the breast-within-breast artifact. In the clinical setting (n = 5), workflow and image quality were not influenced by the I-STRIP. The mean IMT of these invasive breast cancers was 2.1 mg l/cm2 (range 1.3-3.4 mg l/cm2). Malignant lesions showed significantly higher CGV's than benign lesions (p = 0.002).

CONCLUSION: We showed in both phantom and clinical experiments that CESM quantification is feasible, without influencing workflow or image quality. The current CESM imaging protocol seems to be able to distinguish between benign and malignant breast lesions in terms of CGV.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Lobbes MBI, Mulder HKP, Rousch M, et al. Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): A proof-of-concept study. Eur J Radiol. 2018. PMID: 30150032. doi:10.1016/j.ejrad.2018.07.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。